CD133-positive tumor cell content is a predictor of early recurrence in colorectal cancer

Journal of Gastrointestinal Oncology

Joon Oh Park¹  Kyoung-Mee Kim²  Seung Tae Kim¹  Sung Hee Lim¹  Hee Cheol Kim³  Jiryeon Jang¹  Jeeyun Lee¹  Young Suk Park¹ 

[1] Division of Hematology-Oncology,Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDivision of Hematology-Oncology,Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDivision of Hematology-Oncology,Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;Department of Pathology,Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDepartment of Pathology,Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDepartment of Pathology,Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

关键词: CD133;    colorectal cancer;    cancer stem cell;   

DOI  :  10.3978/j.issn.2078-6891.2014.071

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown